文献
J-GLOBAL ID:201702230100133312
整理番号:17A0997492
酢酸アビラテロンではなく,エンザルタミドを受けているドセタキセルナイーブ,転移性去勢抵抗性前立腺癌患者における前立腺特異抗原(PSA)天底とPSA無増悪生存期間への時間との独立した関連【Powered by NICT】
Independent association between time to prostate-specific antigen (PSA) nadir and PSA progression-free survival in patients with docetaxel-naieve, metastatic castration-resistant prostate cancer receiving abiraterone acetate, but not enzalutamide
著者 (8件):
Miyake Hideaki
(Department of Urology, Hamamatsu University School of Medicine, Hamamatsu, Japan)
,
Miyake Hideaki
(Division of Urology, Kobe University Graduate School of Medicine, Kobe, Japan)
,
Hara Takuto
(Division of Urology, Kobe University Graduate School of Medicine, Kobe, Japan)
,
Tamura Keita
(Department of Urology, Hamamatsu University School of Medicine, Hamamatsu, Japan)
,
Sugiyama Takayuki
(Department of Urology, Hamamatsu University School of Medicine, Hamamatsu, Japan)
,
Furuse Hiroshi
(Department of Urology, Hamamatsu University School of Medicine, Hamamatsu, Japan)
,
Ozono Seiichiro
(Department of Urology, Hamamatsu University School of Medicine, Hamamatsu, Japan)
,
Fujisawa Masato
(Division of Urology, Kobe University Graduate School of Medicine, Kobe, Japan)
資料名:
Urologic Oncology: Seminars and Original Investigations
(Urologic Oncology: Seminars and Original Investigations)
巻:
35
号:
6
ページ:
432-437
発行年:
2017年
JST資料番号:
W3220A
ISSN:
1078-1439
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)